Press release
The Xerostomia (Dry Mouth) Treatment market to grow in concurrence with technological upgradations in the next decade
Xerostomia, commonly known as dry mouth, is defined as a condition resulting in the limited production of saliva or alteration in the saliva quality to retain the mouth wet. Xerostomia is normally caused due to a variety of factors such as side-effects from medication, dehydration, surgery, mouth bleeding, smoking, and irradiation of neck and head. The xerostomia is not classified as a disease but as symptoms of variable disorders. Xerostomia is potent in geriatric population affecting more than 20% of the elderly individuals, and are often associated or not with the functionality of salivary glands. Xerostomia is majorly coupled with the other disorders such as burning sensation, verbal difficulties and gulping, sore throat, and hoarseness. If remain untreated, they result in oral pH decrease and increase the probability of developing plaque and dental caries. The condition of xerostomia can be managed through self-care, intake of artificial saliva or saliva substitutes such as carboxymethyl, mucopolysaccharides solutions, and others, and other medication involves saliva stimulants such as pilocarpine, cevimeline, and many others. In addition, the most common cause of xerostomia is Sjogren’s syndrome, HIV and cancer patients.For more insights into the Market, request a sample of this report @ https://www.persistencemarketresearch.com/samples/17236
Xerostomia (Dry Mouth) Treatment Market: Drivers and Restraints
The growth of xerostomia is mainly driven by the increasing prevalence of the associated diseases, and the most common is Sjogren’s syndrome. According to the estimates of American College of Rheumatology, approximately 3.1 million are suffering from Sjogren’s syndrome out of 4 million individuals. However, the xerostomia treatment market can be hampered by the factor such as lack of awareness among the people of developing and under developed economies owing to the fact, xerostomia is can consider as general or minor disorders. The other factor impeding the growth of xerostomia treatment market is non-availability of the effective treatment. As exemplified by The Cochrane Collaboration research, in 2011, that there is no strong evidence supporting the optimum effectiveness for the treatment of xerostomia.
For Information On The Research Methodology request here @ https://www.persistencemarketresearch.com/methodology/17236
Xerostomia (Dry Mouth) Treatment Market: Segmentation
24The global xerostomia treatment market can be segmented on the basis of product type, distribution channel, and region.
On the basis of product type global xerostomia treatment market can be segmented as:
• Artificial Saliva
• Salivary Stimulants
• Saliva Substitutes
• Drugs
• Salivary Pens
• Others
On the basis of distribution channel global xerostomia treatment market can be segmented as:
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• Drugs Stores
On the basis of region global xerostomia treatment market can be segmented as:
• North America
• Latin America
• Europe
• Asia Pacific
• Middle East and Africa
To receive extensive list of important regions, Request TOC here @ https://www.persistencemarketresearch.com/toc/17236
Xerostomia (Dry Mouth) Treatment Market: Overview
Xerostomia treatment market is expected to show a tremendous growth during the forecast period. Xerostomia can be caused due to toxicity during chemotherapy, adverse drug reactions, diabetes, infections, hormonal alterations and autoimmune disorders resulting in triggering complications in the tasting, communication, mastication, and gulping. In addition, increases the chances of causing tooth decay, demineralization and sensitivity, and oral infections. Xerostomia treatment market is primarily driven by the easy availability of medication and its cost effectiveness. Consistent product launching by the various player also impels the growth of xerostomia market. For instance, Forward Science LLC, in February 2016, launched the product named, SalivaMax for the treatment of xerostomia and can be used in cancer therapies.
Xerostomia (Dry Mouth) Treatment Market: Region Wise Outlook
Geographically, global xerostomia treatment market can be segmented as North America, Latin America, Europe, Asia-Pacific and Middle East & Africa. North America is most attractive xerostomia treatment market followed by Europe owing to better and increasing healthcare infrastructure and facilities, easy availability of treatment options, and favorable reimbursement policies. Asia-Pacific region is estimated to grow at fastest CAGR over the forecast period owing to the rising number of geriatric population base in countries like Japan, China, and India. However, the regions such as Latin America and Middle East and Africa show a stagnant growth during the forecast year due to the lack of awareness among the people and scarcity of skilled professionals to avail the proper treatment options.
Xerostomia (Dry Mouth) Treatment Market: Key Players
Some of the market participants in the global xerostomia treatment are Eisai Inc., Colgate-Palmolive Company, Dentaid, EUSA Pharma, Forward Science, GlaxoSmithKline plc, Mission Pharmacal Company, OraHealth Inc., OraPharma, Inc. (A subsidary of Valeant Pharmaceuticals International, Inc.), Parnell Pharmaceuticals, Inc., Saliwell Ltd., and Sun Pharmaceutical Industries Limited.
Explore Extensive Coverage of PMR`s Life Sciences & Transformational Health Landscape
About us:
Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.
To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.
Our client success stories feature a range of clients from Fortune 500 companies to fast-growing startups. PMR’s collaborative environment is committed to building industry-specific solutions by transforming data from multiple streams into a strategic asset.
Contact us:
Naved Beg
Persistence Market Research
Address – 305 Broadway, 7th Floor New York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com
Persistence Market Research (PMR) is an innovative and specialized publisher of market intelligence reports and consulting services. Prompt delivery, in-depth research, and high quality are the sacrosanct principles of PMR.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release The Xerostomia (Dry Mouth) Treatment market to grow in concurrence with technological upgradations in the next decade here
News-ID: 2175983 • Views: …
More Releases from Persistence Market Research

Plastic Liner Market to Reach US$ 6.67 Bn by 2030, Expanding at 4.7% CAGR - Pers …
➤ Overview of the Market
The global plastic liner market has gained steady traction across multiple industries due to its cost-effectiveness, versatility, and protective characteristics. Plastic liners are widely used in agriculture, mining, construction, waste management, and packaging industries, where they serve as an essential barrier to prevent leakage, contamination, and material loss. These liners are manufactured using materials such as polyethylene (PE), polypropylene (PP), and PVC, offering superior resistance to…

Returnable Plastic Crate Market to Reach US$ 2,665.1 Million by 2030 Fueled by S …
➤ Overview of the Market
The global returnable plastic crate market is gaining momentum as industries seek cost-effective and sustainable packaging solutions. These crates are widely used for transporting and storing perishable goods, beverages, pharmaceuticals, and industrial products due to their durability, stackability, and reusability. The shift from single-use packaging to eco-friendly alternatives has accelerated the adoption of returnable plastic crates across sectors. The market, valued at US$ 1,820.0 million in…

US Thermal Power Market Expected to Reach US$ 251.9 Mn by 2031 with 2.4% CAGR Gr …
➤Overview of the Market
The US thermal power market plays a crucial role in the nation's energy mix, serving as a stable and reliable source of electricity despite the rise of renewables. Thermal power plants in the US rely primarily on coal, natural gas, and oil to generate electricity, with natural gas emerging as the dominant fuel source due to its affordability, efficiency, and lower carbon footprint compared to coal. According…

Europe Medical Plastic Market to Reach US$ 17 Bn by 2032 Driven by Rising Health …
➤Overview of the Market
The Europe medical plastic market is undergoing robust growth, fueled by increasing demand for lightweight, durable, and cost-effective materials in the healthcare sector. Medical plastics are widely used in devices, surgical instruments, diagnostic tools, implants, and packaging due to their high biocompatibility, versatility, and resistance to sterilization methods. With healthcare systems across Europe investing heavily in modernization and patient safety, the adoption of medical-grade plastics has gained…
More Releases for Xerostomia
Xerostomia Therapeutics Market - Expansion & Opportunities Ahead 2025-2035
23 April 2025, Metatech Insights - The Global Research Report Provides a Detailed Analysis of Xerostomia Therapeutics Market, Based on Competitive Intensity and How the Competition Will Take Shape in Coming Years.
Latest released the research study on Global Xerostomia Therapeutics Market, offers a detailed overview of the factors influencing the global business scope. Xerostomia Therapeutics Market research report shows the latest market insights, current situation analysis with upcoming trends and…
Top Factor Driving Xerostomia Therapeutics Market Growth in 2025: Chemotherapy's …
Get 20% off on all our 2025 Global Market Reports with code FY25SAVE - Offer valid till March 31st! …
Top Factor Driving Xerostomia Therapeutics Market Growth in 2025: Chemotherapy's …
Get 20% off on all our 2025 Global Market Reports with code FY25SAVE - Offer valid till March 31st! …
Xerostomia (Dry Mouth) Market: An In-Depth Analysis
𝐓𝐡𝐞 𝐠𝐥𝐨𝐛𝐚𝐥 𝐗𝐞𝐫𝐨𝐬𝐭𝐨𝐦𝐢𝐚 (𝐝𝐫𝐲 𝐦𝐨𝐮𝐭𝐡) 𝐦𝐚𝐫𝐤𝐞𝐭 𝐰𝐚𝐬 𝐯𝐚𝐥𝐮𝐞𝐝 𝐚𝐭 𝐚𝐩𝐩𝐫𝐨𝐱𝐢𝐦𝐚𝐭𝐞𝐥𝐲 𝐔𝐒𝐃 𝟐.𝟏 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐢𝐧 𝟐𝟎𝟐𝟑 𝐚𝐧𝐝 𝐢𝐬 𝐩𝐫𝐨𝐣𝐞𝐜𝐭𝐞𝐝 𝐭𝐨 𝐫𝐞𝐚𝐜𝐡 𝐚𝐫𝐨𝐮𝐧𝐝 𝐔𝐒𝐃 𝟑.𝟏 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐛𝐲 𝟐𝟎𝟑𝟐, 𝐫𝐞𝐟𝐥𝐞𝐜𝐭𝐢𝐧𝐠 𝐚 𝐜𝐨𝐦𝐩𝐨𝐮𝐧𝐝 𝐚𝐧𝐧𝐮𝐚𝐥 𝐠𝐫𝐨𝐰𝐭𝐡 𝐫𝐚𝐭𝐞 (𝐂𝐀𝐆𝐑) 𝐨𝐟 𝟒.𝟏%.
𝐗𝐞𝐫𝐨𝐬𝐭𝐨𝐦𝐢𝐚 (𝐃𝐫𝐲 𝐌𝐨𝐮𝐭𝐡) 𝐌𝐚𝐫𝐤𝐞𝐭 𝐎𝐯𝐞𝐫𝐯𝐢𝐞𝐰
The xerostomia (dry mouth) market is growing due to the increasing prevalence of conditions such as diabetes, Sjögren's syndrome, and cancer treatments like radiation therapy, which contribute to dry mouth symptoms. The…
Xerostomia Therapeutics Market Analysis, Size, Share & Trends | 2031
In recent years, the global Xerostomia Therapeutics Market has witnessed a dynamic shift, influenced by changing consumer preferences, technological advancements, and a growing emphasis on sustainability. The Research report on Xerostomia Therapeutics Market presents a complete judgment of the market through strategic insights on future trends, growth factors, supplier landscape, demand landscape, Y-o-Y growth rate, CAGR, pricing analysis. It also provides and a lot of business matrices including Porters Five…
Xerostomia Treatment Market Size, Share, Report and Forecast 2032
Xerostomia Treatment Market Outlook
The xerostomia treatment market is anticipated to grow at a CAGR of 3.5 % during the forecast period of 2024-2032.
Xerostomia Treatment: Introduction
Xerostomia, commonly known as dry mouth, is a condition characterised by a significant decrease in saliva production. This can lead to discomfort, difficulties in speaking, chewing, and swallowing, as well as an increased risk of dental decay and oral infections. Xerostomia treatment aims to alleviate these…